D.E. Shaw & Co
ONC

D.E. Shaw & Co’s BeOne Medicines Ltd ONC Stock Holding History

D.E. Shaw & Co’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,100
Closed -$638K – 5173
2025
Q4 		$638K Buy
2,100
+500
+31% +$164K ﹤0.01% 3803
2025
Q3 		$545K Hold
1,600
– – ﹤0.01% 3821
2025
Q2 		$387K Buy
+1,600
New +$392K ﹤0.01% 3754
2022
Q2 		– Sell
-6,200
Closed -$1.17M – 5853
2022
Q1 		$1.17M Hold
6,200
– – ﹤0.01% 3776
2021
Q4 		$1.68M Buy
+6,200
New +$2.09M ﹤0.01% 3512

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return